Recall Process Workflow | GMPify Training

📦

Recall Process - Removing a Defective Product from Distribution

A recall is initiated when a firm identifies that a marketed product may violate the FD&C Act and poses a health risk or quality defect that warrants removal from the market. FDA classifies every recall as Class I, Class II, or Class III based on the health hazard involved, and that classification drives the depth of the recall, the urgency of notification, and whether public communication is required. This map details the pathway from initial defect detection through classification, execution, and eventual termination.

21 CFR Part 7 Subpart C · FDA RPM Chapter 7 · Health Canada RG-1

21 CFR Part 7

RPM Chapter 7

RG-1

Class I Recall

Reasonable probability that use of the product will cause serious adverse health consequences or death.

Severity: Most serious

Class II Recall

Product may cause temporary or medically reversible adverse health consequences, with remote probability of serious consequences.

Severity: Moderate

Class III Recall

Product is not likely to cause any adverse health consequences, typically involving minor GMP or labeling deviations.

Severity: Least serious

Market Withdrawal / Stock Recovery

Correction of a minor violation that would not be subject to legal action, handled without a formal recall classification.

Severity: Not a formal recall

Phase 1

Defect Detection and Initial Assessment

1Identify a potential product defect or hazard

Defect identified through a complaint, internal deviation, stability failure, adverse event report, or supplier notification.

Internal SOP

↓

2Convene the recall committee and quality leadership

Cross-functional recall committee convened immediately, including quality, regulatory affairs, medical, and executive leadership.

Internal SOP

↓

3Conduct initial health hazard evaluation

Preliminary evaluation conducted to assess the likelihood and severity of adverse health consequences from the defect.

FDA RPM Chapter 7

↓

4Determine the scope of affected batches or lots

Investigation identifies every batch, lot, and distribution point potentially affected by the same defect.

21 CFR 211.192

Phase 2

Classification and Strategy Development

5Classify the recall

Recall classified as Class I, Class II, or Class III based on the health hazard evaluation and FDA's classification criteria.

21 CFR Part 7 Subpart C

↓

6Develop the recall strategy

Strategy defined covering recall depth, level of trade, and method of notification appropriate to the classification.

FDA RPM Chapter 7

↓

7Notify FDA of the recall

Recall communicated to the appropriate FDA district office, including the health hazard evaluation and proposed strategy.

21 CFR 7.46

↓

Is this a Class I or significant public health risk recall?

YES → Issue public press release NO → Standard notification only

Phase 3

Recall Execution and Notification

8Notify the distribution chain

Every consignee within the recall's defined depth identified and prepared to receive formal recall notification.

21 CFR 7.49

↓

9Issue recall notification letters

Formal recall communication issued identifying the product, the reason for recall, and instructions for return or destruction.

21 CFR 7.49

↓

10Conduct effectiveness checks

Effectiveness checks performed at the level and frequency appropriate to the recall's classification and assigned check level.

21 CFR 7.53

Phase 4

Effectiveness Checks and Termination

11Track and reconcile returned or destroyed product

Quantity of recalled product returned, destroyed, or corrected reconciled against the quantity originally distributed.

Internal SOP

↓

12Submit periodic status reports to FDA

Status reports submitted at the intervals specified by the district office, documenting recall progress and reconciliation.

21 CFR 7.53

↓

13Request recall termination from FDA

Termination requested once reconciliation is complete and effectiveness checks confirm the recall achieved its objective.

FDA RPM Chapter 7

Recall Classification (Overview)

Class I

Reasonable probability of serious adverse health consequences or death from use of the product.

Most serious

Class II

Temporary or reversible adverse health consequences, with only remote probability of serious harm.

Moderate

Class III

Not likely to cause any adverse health consequences, typically a labeling or minor quality defect.

Least serious

Recall Depth Levels (Overview)

Consumer / User level The deepest level, extending the recall all the way to the individual consumer or patient.

Retail level Recall extends to the retail pharmacy or point of sale but not to individual consumers already dispensed product.

Wholesale level The shallowest level, limited to distributors and wholesalers before product reaches retail or consumers.

Classification drives depth A Class I recall typically requires consumer-level depth, while a Class III recall may only reach wholesale level.

Key Recall Outputs (Overview)

Recall strategy document Formal document defining classification, depth, level of trade, and notification method submitted to FDA.

Public press release Issued for Class I recalls or where significant public health risk warrants direct public communication.

Effectiveness check results Documented confirmation that consignees received and acted on the recall notification as required.

Recall termination letter Formal FDA confirmation that the recall is complete and the firm's obligations under the recall are closed.

Recall Process Quality Elements

Rapid Defect Detection Complaints, deviations, and adverse event signals evaluated promptly for potential recall triggers.

Health Hazard Evaluation Rigor Initial evaluation conducted thoroughly and promptly to support an accurate classification decision.

Accurate Batch Scope Determination Every batch, lot, and distribution point sharing the same defect identified before the recall strategy is finalized.

Classification Accuracy Recall classified consistently with FDA's Class I, II, and III criteria based on the actual health hazard involved.

Distribution Chain Traceability Complete and current distribution records enabling every consignee within scope to be identified and notified.

Effectiveness Check Completion Effectiveness checks completed at the required level and frequency, with results documented and reported.

Regulatory Reporting Timeliness Status reports submitted to FDA at the intervals specified throughout the recall's duration.

Root Cause CAPA Linkage Recall linked to a root cause investigation and CAPA addressing the underlying defect, not only the affected lots.

Never do this

Delay convening the recall committee while awaiting complete root cause certainty. Classify the recall without a documented health hazard evaluation. Limit distribution notification to only the lots first identified without confirming full scope. Close the recall before reconciliation and effectiveness checks are complete.

Recall vs market withdrawal

A recall addresses a violation of the FD&C Act and is formally classified by FDA. A market withdrawal addresses a minor problem that would not be subject to legal action, such as normal stock rotation, and does not carry a formal recall classification.

Class I vs II vs III

Class I involves a reasonable probability of serious health consequences or death. Class II involves temporary or reversible consequences with only remote probability of serious harm. Class III is not likely to cause any adverse health consequences at all.

Key regulations

21 CFR Part 7 Subpart C - FDA recall regulations and classification criteria. FDA Regulatory Procedures Manual Chapter 7 - agency procedures for recall oversight. Health Canada RG-1 - equivalent Canadian recall guidance and classification framework.